Skip to main navigation Skip to search Skip to main content

An Investigation into the effects of Dapagliflozin on Ketogensis in Type 1 Diabetes

Project: Research

Project Details

StatusFinished
Effective start/end date05/13/1612/31/25

Funding

  • AstraZeneca Pharmaceuticals LP: $722,709.00